PA
ORGO icon

Parallel Advisors’s Organogenesis Holdings ORGO Stock Holding History

Parallel Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-106
Closed -$458 – 3663
2025
Q1 		$458 Buy
106
+18
+20% +$73 ﹤0.01% 3249
2024
Q4 		$282 Buy
+88
New +$295 ﹤0.01% 3327
2022
Q2 		– Sell
-11
Closed – – 3252
2022
Q1 		$0 Buy
+11
New +$85 ﹤0.01% 3182

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parallel Advisors's ORGO Position: Q2 2025 in Review

Parallel Advisors sold out of Organogenesis Holdings (ORGO) in Q2 2025, closing a stake of 106 shares — an estimated $458 sold.

Parallel Advisors first reported a position in ORGO in Q1 2022 and held it in 3 quarters. The position peaked at $458 in Q1 2025. 115 funds tracked by Wall St. Rank hold ORGO as of Q2 2025.

  • Parallel Advisors reported no remaining Organogenesis Holdings position as of Q2 2025 after selling out during the quarter.
  • Parallel Advisors sold 106 Organogenesis Holdings shares in Q2 2025, an estimated $458.
  • Parallel Advisors first reported a position in Organogenesis Holdings in Q1 2022 and held it in 3 quarters.
  • Parallel Advisors's Organogenesis Holdings position peaked at $458 in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.